Prior Authorization Costs Physicians 13 Hours a Week and Most Denials Go Unappealed

Prior authorization automation reduces the manual work of submitting, tracking and appealing payer approvals. It matters because physicians and staff spend 13 hours per week on prior authorization, according to the American Medical Association's 2025 survey of practicing physicians. The larger opportunity is not speed. It is the denied claims that practices never appeal.

Thirteen hours a week is a headcount decision

Administrative burden is usually discussed in the language of frustration. Prior authorization deserves the language of operations. The AMA fielded its 2025 Prior Authorization Physician Survey in December 2025 across 1,000 practicing physicians. It found that physicians and staff spend 13 hours per week on prior authorization and complete 40 prior authorizations per week.

Those two figures together describe a work center. Forty transactions moving through a process that consumes 13 hours of clinical and clerical time is not overhead. It is a production line with a throughput requirement, a queue, a cycle time and a failure rate. Every operating discipline that applies to a production line applies here.

The AMA also found that 40 percent of practices have staff working exclusively on prior authorization. That is the honest version of the number. Once volume passes a threshold, practices stop absorbing the work into existing roles and create a dedicated function.

The practices that have not made that decision are still doing the work. They do it in fragments, between patients, after hours, spread across people whose job descriptions say something else. The cost does not disappear because it was never budgeted. It shows up as slower scheduling, later charge entry and staff who spend their day on hold.

The appeal gap is where the money sits

Denials are rising and physicians know it. Seventy-four percent of physicians told the AMA in 2025 that prior authorization denials increased over the previous five years. Twenty-one percent say their prior authorizations are often or always denied.

The response to that pressure is the more revealing finding. Only 32 percent of physicians always appeal an adverse determination, according to the same AMA survey. Most denials that a practice believes are wrong are simply absorbed into the write-off column.

The stated reasons matter more than the rate itself. Among physicians who do not appeal, 59 percent do not expect success, 52 percent cite insufficient staff time and 49 percent say care cannot wait, per the AMA. Only the first of those three reasons concerns the merits of the claim.

Two of the three reasons are operational, not clinical

Insufficient staff time is a capacity constraint. Care that cannot wait is a cycle time constraint. Neither one says the denial was correct. Both say the practice lacked the operational room to contest a determination it disagreed with.

That distinction changes the nature of the problem. A practice that declines to appeal because the payer was right has a documentation problem at the front end. A practice that declines to appeal because nobody has the hours has a revenue cycle problem with a staffing cause.

Denial management is normally treated as a downstream billing activity that happens after a claim is rejected. Prior authorization denials do not behave that way. They arrive before the service is rendered, they carry a clinical deadline, and the window to contest them closes while a patient waits for care.

The result is a category of recoverable revenue that never enters the accounts receivable aging report at all. Nothing was billed. Nothing was denied on a remittance. The service simply did not happen, and no report in the practice management system flags it.

Denial rates are a payer behavior, not a fact of nature

Practices often treat denials as the fixed price of a particular payer contract. The variation across payers is real, and it is wider than most contracting conversations acknowledge. KFF analysis of CMS federal transparency data for 2024 found an average in-network claim denial rate of 19 percent in HealthCare.gov marketplace plans. Rates ranged from 13 to 35 percent across the largest insurers.

A spread that wide among insurers operating under the same rules says something about utilization management practice rather than clinical necessity. Payers make different choices about how much friction to introduce into the approval path. Those choices land on practice staff and on patients.

Burden also varies sharply by line of business. AMA respondents in 2025 rated Medicare Advantage as high or extremely high burden at 69 percent, commercial plans at 63 percent and Medicaid at 47 percent. A practice weighted toward Medicare Advantage runs a materially different back office than one weighted toward Medicaid.

Payer contract negotiation rarely addresses any of this directly. Rate gets negotiated. Authorization friction gets inherited. Practices that track denial volume, appeal rate and appeal outcomes by payer arrive at renewal with evidence instead of complaints, and evidence is what moves a utilization management conversation.

What automation removes and what it leaves behind

The tooling landscape is thinner than vendor messaging suggests. Only 24 percent of electronic health records offer electronic prior authorization for prescriptions, according to the AMA in 2025. Only 5 percent of practices report access to gold-card or exemption programs.

Gold carding is the structural fix rather than the mechanical one. When a payer exempts a physician with a strong approval history from authorization requirements on defined services, the work disappears instead of accelerating. At 5 percent adoption, gold carding is a negotiating objective for most practices rather than a current-state benefit.

Automation compresses the transaction, not the decision

Software handles the mechanical layer well. Eligibility verification at the point of scheduling, benefit checks against the payer file, pulling clinical documentation from the chart into the submission, routing through a clearinghouse, and tracking status without a telephone call all respond to automation.

Software does not make the determination. The payer's utilization management criteria still governs the outcome. Automation moves a case to that decision faster and with fewer defects, which raises clean claim rate and pulls down days in accounts receivable tied to authorization holds.

The real return is recovered capacity. Hours reclaimed from status calls and duplicate data entry become hours available for appeals, which is precisely the constraint that 52 percent of non-appealing physicians named in the AMA survey. Automation that saves time without redirecting it produces a quieter office and the same write-offs.

Designing the staffing model around the queue

Most practices staff prior authorization by accident. A capable person absorbed the work, the volume grew, and the task became that person's job without ever becoming a defined role. The result is a single point of failure operating an undocumented process with no service level.

A designed model looks materially different. Authorization requirements are checked during scheduling rather than on the day of service. Documentation standards are written per payer and per procedure before anything is submitted. Denials route to a named owner with an appeal deadline attached and a default assumption that an appeal will be filed.

That last point is the pivot. Appeals should require a reason to skip, not a reason to pursue. Reversing the default is a policy change that costs nothing and directly addresses the finding that only 32 percent of physicians always appeal.

This is ordinary operations work applied to a clinical administrative function, and most practices have nobody whose job is to do it. Practices without a full-time operations executive frequently bring in fractional COO support to build the workflow, define the metrics and hand a running function back to the internal team.

The metrics that make automation measurable

The measurement set is not exotic. Authorization turnaround time, denial rate segmented by payer and procedure, appeal rate, appeal win rate, and days in accounts receivable attributable to authorization holds cover the operating picture.

Practices that cannot produce those figures cannot tell whether an automation purchase worked. They will feel busier or less busy and call that a result. A baseline captured before implementation is the cheapest part of the project and the part most often skipped.

The burnout number is a retention number

Ninety-four percent of physicians say prior authorization increases physician burnout, per the AMA in 2025. The clinical consequences track alongside it. Ninety-five percent report care delays, 92 percent report negative clinical impact, and 26 percent report a serious adverse event resulting from the process.

Those figures are normally cited in support of policy reform, and they belong in that argument. They also belong in a staffing conversation. Physician time spent chasing authorization is the most expensive labor in the building applied to the least clinical task available to it.

Practices that move authorization work off physicians and onto a trained, properly tooled administrative function collect two returns. Cost per transaction falls because the work sits at the right wage level. The people most likely to leave stop spending their week on the activity that makes them want to leave.

The appeal statistics describe practices declining to collect money they believe they are owed. That choice is rational under a capacity constraint and expensive under every other reading. Prior authorization automation is worth buying, but the case for it is not the hours it returns. The case is what a practice decides to do with those hours once they exist, and the honest answer for most practices is that nobody has decided yet.

Frequently Asked Questions

What does prior authorization automation actually automate?
Automation handles the transactional layer of the process rather than the clinical determination. That includes eligibility verification at scheduling, benefit checks, assembling documentation from the chart, submitting through a clearinghouse and monitoring status without phone calls. The payer still applies its own utilization management criteria to decide the case. Practices that expect approval rates to change from software alone are measuring the wrong outcome.

How do I know whether my practice should appeal more denials?
The test is why appeals are being skipped rather than how many are filed. The AMA reported in 2025 that among physicians who do not appeal, 52 percent cite insufficient staff time and 49 percent say care cannot wait. Both reasons are operational and neither indicates the denial was clinically correct. A practice that cannot separate merit-based decisions from capacity-based ones is leaving recoverable revenue uncounted.

Should a practice hire dedicated prior authorization staff?
Dedicated staffing becomes justified when volume is steady enough to keep a specialist productive and complex enough that generalists make errors. The AMA found in 2025 that 40 percent of practices already have staff working exclusively on prior authorization. The alternative is not zero cost, because the work is still performed by clinical staff at a higher wage and with more interruption. Practices should price the current arrangement before deciding it is cheaper.

What is gold carding and can a mid-market practice obtain it?
Gold carding exempts physicians with strong approval histories from authorization requirements on specified services. The AMA reported in 2025 that only 5 percent of practices have access to gold-card or exemption programs, so it remains rare. Obtaining it requires clean historical approval data organized by payer and procedure, which most practices do not currently produce. Building that reporting is a prerequisite for the conversation, not an outcome of it.

How does prior authorization affect days in accounts receivable?
Authorization holds delay the service, which delays the charge, which delays the claim. The effect appears as aged receivable and as revenue that never entered the cycle because the service was abandoned. Tracking days in accounts receivable attributable specifically to authorization holds separates this from ordinary billing lag. Without that segmentation, revenue cycle reporting misattributes the cause and the fix lands in the wrong department.

Which payers should a practice examine first?
Burden concentrates unevenly across lines of business. AMA respondents in 2025 rated Medicare Advantage as high or extremely high burden at 69 percent, commercial plans at 63 percent and Medicaid at 47 percent. Denial behavior also varies widely by insurer, with KFF analysis of CMS data for 2024 showing marketplace in-network denial rates from 13 to 35 percent across the largest insurers. Practices should start with the payer combining high volume, high burden and high denial rate, because that is where process investment returns fastest.

Practices Are Not Selling Because They Are Failing. They Are Selling for Negotiating Power

Physician practice management is the operating discipline of running a medical practice as a business: payer contracting, revenue cycle, staffing and compliance. The reason it matters now is what sellers actually say. The AMA found that 70.8 percent of practices that sold cited the ability to negotiate higher payment rates. That is a contracting problem, not a distress signal.

The stated reasons for selling are not distress reasons

The standard account of practice consolidation describes exhausted physicians and failing economics. Sellers describe something more specific. The AMA Physician Practice Benchmark Survey for 2024, drawn from 5,000 physicians at a 43 percent response rate, asked practices that sold why they did it.

The top answer was payment rates. Seventy point eight percent cited the ability to negotiate higher payment rates as a reason for the sale. The next two answers were access to costly resources at 64.9 percent and managing payer regulatory and administrative requirements at 63.6 percent.

Read those three together and a picture forms that has nothing to do with a practice running out of patients. All three describe a relationship with payers rather than a relationship with patients. Practices are not exiting a broken market. They are exiting a weak negotiating position.

That distinction changes the entire diagnostic. A failing practice has an operations problem, a demand problem or a cost problem, and each has known remedies. A practice that sells for rate improvement has none of those. It has a bargaining problem, and bargaining power comes from structure.

What negotiating position is actually made of

Payer contracting rewards a short list of attributes and practice quality is not first among them. Network adequacy sits at the top. A payer that cannot build an adequate network in a geography without a particular group will pay that group differently.

Patient volume and geographic coverage follow. A group representing a meaningful share of a specialty in a market has a credible alternative to accepting terms. A practice representing a small fraction does not, regardless of outcomes or patient satisfaction.

Data comes third and is the most neglected. Practices that can demonstrate cost per episode, referral patterns, quality measures and utilization performance can argue from evidence. Most independent practices cannot produce those figures, which reduces negotiation to accepting a fee schedule as presented.

Nothing on that list correlates with clinical excellence at the individual practice level. That is the uncomfortable part of the finding. Physicians are being asked to solve a structural problem with professional merit, and merit is not the currency being priced.

The practical consequence shows up every renewal cycle. A practice requests an increase, receives a standard response, and concludes the payer is unreasonable. The payer is behaving rationally toward a counterparty with no alternative to offer.

Fragmentation is the underlying condition

The scale picture explains why so few practices hold a strong position. US Census County Business Patterns for 2023 counts 204,617 offices of physicians establishments averaging 13.2 employees, with 52.7 percent having fewer than five.

The AMA data agrees from a different angle. Physicians in practices of ten or fewer fell to 47.4 percent in 2024, below half for the first time, and 49.2 percent of private-practice physicians work in practices of fewer than five physicians.

An industry composed largely of very small units facing a small number of very large payers has a predictable outcome. The counterparty with concentration sets terms. The counterparty with fragmentation accepts them and calls the result market rates.

Consolidation is the market solving that imbalance in the crudest available way. Practices merge into entities large enough to be negotiated with rather than dictated to. Every seller in that 70.8 percent figure is buying a seat at a table they could not otherwise reach.

The destination is employment, not partnership

The transaction is frequently described as joining a larger group. The aggregate data describes something more definitive. Physicians in wholly physician-owned practices fell to 42.2 percent in 2024 from 60.1 percent in 2012, per the AMA.

Hospital-owned practice participation rose to 34.5 percent from 23.4 percent over the same period. Physicians employed directly by a hospital rose to 12.2 percent from 5.6 percent in 2012.

The employment share tells the plainest version. The AMA reports 57.5 percent of physicians are employees and 7.1 percent are independent contractors as of 2024. A majority of American physicians now work for someone else.

Rate improvement obtained through acquisition arrives bundled with governance changes that no contract negotiation would have produced. Scheduling, staffing ratios, referral direction and technology decisions transfer with the ownership stake. Physicians who sold for a payer contracting reason acquired a much broader set of consequences.

None of that makes the decision wrong. It makes the accounting incomplete. A rate increase quantified in advance sits against governance costs that surface gradually and are rarely modeled during diligence.

The open question about scale and independence

The honest position is that scale genuinely works for rate negotiation, and no operating improvement fully substitutes for it. Pretending otherwise sets independent practices up for disappointment. The productive question is how much bargaining power is reachable without an equity sale.

Structures that aggregate without acquiring

Independent practice associations exist precisely to negotiate on behalf of practices that remain separately owned. Clinically integrated networks go further, permitting joint contracting where practices demonstrate genuine clinical integration. Both structures carry real legal requirements and neither works as a paper arrangement.

Management services organizations formed by independents deliver the administrative scale without the ownership transfer. Billing, credentialing, human resources, purchasing and technology run once for many practices. That directly addresses the 64.9 percent who cited access to costly resources and the 63.6 percent who cited administrative and regulatory burden.

Value-based contracting offers a different route. A practice that can document total cost of care performance negotiates on outcomes rather than on volume. Payers pay differently for demonstrated savings, and that argument does not require size in the same way a fee schedule negotiation does.

What each route demands first

Every one of these paths requires data the practice does not currently produce. Joining an independent practice association without cost and quality reporting means joining as a passenger. Entering a value-based arrangement without knowing current performance means accepting risk blindly.

Building that reporting capability is an operations project, not a clinical one. It requires someone to define the measures, integrate the sources and hold the reporting cadence. Practices without a full-time operations executive frequently engage fractional COO leadership to build the function before any contracting conversation begins.

The controllable half of the reimbursement problem

While rate negotiation depends on structure, realized revenue depends on execution, and the second half is entirely controllable. Contracted rates only matter to the extent claims are actually paid at them.

Denial behavior varies more than most practices assume. KFF analysis of CMS federal transparency data for 2024 found in-network claim denial rates in marketplace plans averaging 19 percent, with insurer-level variation from 13 to 35 percent.

A practice with strong contracted rates and weak denial management collects less than a practice with modest rates and disciplined revenue cycle operations. Eligibility verification, documentation standards, clean claim rate and appeal discipline determine which of those two a practice becomes.

Denial rate by payer is also negotiating evidence. A practice arriving at renewal able to demonstrate that one insurer denies far above the others has changed the conversation from a rate request into a performance discussion. Most practices arrive with neither the data nor the framing.

Group purchasing works the same way on the cost side. Supplies, malpractice coverage, technology contracts and staffing services are all priced against volume that independents can aggregate without merging. The savings are smaller than a rate increase and considerably easier to obtain.

Reframing the decision

Practices considering a sale usually evaluate the offer against the status quo. That comparison is incomplete because the status quo already assumes the practice will not change how it operates or contracts.

The fuller comparison includes a third option. Build the reporting, join or form an aggregating structure, fix the revenue cycle, then evaluate offers from a stronger position. A practice that does this either negotiates better independently or sells at better terms, and both outcomes beat the current path.

Time is the real constraint. Aggregating structures take years to establish and value-based track records take years to accumulate. Practices that begin the work while an offer is on the table have already lost the option they are trying to preserve.

Administrative burden deserves the same treatment. It is genuinely heavy, and it is also the component most improved by process design rather than by ownership change. Practices that fix it internally remove one of the three reasons sellers gave.

The most cited reason practices sell is a negotiating problem wearing the costume of an economic one. That is worth sitting with, because negotiating problems have structural answers and economic problems do not always. The question independent medicine has not seriously answered is whether physicians are willing to build the shared infrastructure that would make independence viable, or whether selling remains simply easier than organizing.

Frequently Asked Questions

Why do practices sell if they are financially stable?
The survey evidence points to contracting position rather than financial distress. The AMA found for 2024 that 70.8 percent of practices that sold cited the ability to negotiate higher payment rates as a reason, followed by 64.9 percent citing access to costly resources and 63.6 percent citing payer regulatory and administrative requirements. None of those three describes failing demand or unsustainable cost. Stable practices sell because the ceiling on independent negotiating position is structural rather than operational.

Can a small practice improve its reimbursement rates without merging?
Improvement is possible but bounded, and the bounds should be stated honestly. Independent practice associations, clinically integrated networks and value-based contracting arrangements allow practices to negotiate with more standing while remaining separately owned. Each requires cost, quality and utilization data that most practices do not currently produce. Building that reporting capability is the prerequisite step, and it takes considerably longer than practices expect.

How much does practice size actually matter to payers?
Size affects network adequacy, which is what payers price. US Census County Business Patterns for 2023 counts 204,617 offices of physicians establishments averaging 13.2 employees, with 52.7 percent having fewer than five. A single practice at that scale rarely represents enough of a specialty in a market to alter a payer's network. Groups large enough to create an adequacy gap negotiate on different terms.

What should my practice fix before entering a payer negotiation?
Reporting comes first because negotiation without evidence is a request rather than a discussion. A practice should be able to produce denial rate and appeal outcomes by payer, cost per episode, referral patterns and quality measures. KFF analysis of CMS data for 2024 showed marketplace in-network denial rates averaging 19 percent with insurer-level variation from 13 to 35 percent, which means payer-specific performance is a real and arguable point. Practices that cannot document their own numbers negotiate against a fee schedule they have no basis to contest.

Is hospital employment different from private equity acquisition for physicians?
The governance outcome is similar even where the structures differ. AMA data for 2024 shows physicians in hospital-owned practices rising to 34.5 percent from 23.4 percent in 2012, and physicians employed directly by a hospital rising to 12.2 percent from 5.6 percent. In both models, decisions about scheduling, staffing and referrals move away from the practicing physician. Physicians evaluating either option should examine the specific governance terms rather than the ownership label.

How long does it take to build an alternative to selling?
Realistically it takes years rather than months. Clinically integrated networks require demonstrated clinical integration, value-based contracts require a performance track record, and management services arrangements require practices willing to standardize their operations. Revenue cycle improvements deliver faster and can begin immediately, which makes them the sensible starting point. Practices that begin only after receiving an acquisition offer have already run out of the time the alternative requires.